Novartis CAR T-cell therapy adds a lymphoma indicationMay 3, 2018Lymphoma & Plasma Cell DisordersFollicular Lymphoma
FDA places partial hold on trials after secondary lymphomaApril 25, 2018Lymphoma & Plasma Cell DisordersFollicular Lymphoma
New genetic subtypes could facilitate precision medicine in DLBCLApril 11, 2018Lymphoma & Plasma Cell Disorders
FDA grants priority review of follicular lymphoma drugApril 11, 2018Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Updated CLL guidelines incorporate a decade of advancesApril 6, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Lenalidomide yields responses in a rare cutaneous lymphomaApril 3, 2018Rare DiseasesLymphoma & Plasma Cell DisordersNonmelanoma Skin Cancer
Ibrutinib plus venetoclax is active in mantle cell lymphomaMarch 28, 2018Lymphoma & Plasma Cell Disorders
Experimental voxtalisib shows mixed results in phase 2 studyMarch 22, 2018Lymphoma & Plasma Cell DisordersFollicular Lymphoma
FDA updates breast implant–associated lymphoma cases, riskMarch 22, 2018Lymphoma & Plasma Cell Disorders
A global snapshot of leukemia incidenceMarch 13, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Outpatient CAR T infusions feasible using liso-celMarch 12, 2018Lymphoma & Plasma Cell DisordersImmunotherapyFollicular Lymphoma
